CUSIP: 71426V108
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,891,261
-
Share change
-
+7,635,100
-
Total reported value
-
$135,525,128
-
Price per share
-
$3.16
-
Number of holders
-
102
-
Value change
-
+$4,996,581
-
Number of buys
-
56
-
Number of sells
-
57
Quarterly Holders Quick Answers
What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 71426V108:
Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q3 2015
As of 30 Sep 2015,
PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,891,261 shares.
The largest 10 holders included
Broadfin Capital, LLC, venBio Select Advisor LLC, ARMISTICE CAPITAL, LLC, BlackRock Fund Advisors, Aisling Capital LLC, Elk Creek Partners, LLC, VANGUARD GROUP INC, TFS CAPITAL LLC, BlackRock Institutional Trust Company, N.A., and Longwood Capital Partners LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.